Market Research Industry Reports

University of British Columbia - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

University of British Columbia (UBC) is a research institute that offers educational services. The university provides undergraduate, graduate educational programs, and research programs through its schools and faculties. It provides cultural, recreational and social activities for its students. UBC offers educational services through programs such a professional programs, English language pathways, joint academic programs, exchange programs, co-operative education, innovative learning initiatives and distance education programs. The university serves adult education needs of lifelong learners by providing educational programs in UBCs Point Grey campus. It operates through peer institutions, government, non-profit and other industries for its research activities. The university operates in two campuses namely, Vancouver Campus and Okanagan Campus. UBC is headquartered in Vancouver, British Columbia, Canada

University of British Columbia - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of British Columbia, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of British Columbia, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
University of British Columbia, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
ProtoKinetix Enters into Research Agreement with University of British Columbia 12
AXIM Biotech Enters into Agreement with University of British Columbia 1
Replicel Life Sciences Enters into Agreement with University of British Columbia 14
Ritter Pharma Enters into Agreement with University of British Columbia 15
TxCell Enters into Research Agreement with University of British Columbia 16
ProtoKinetix Enters into Research Agreement with University of British Columbia 17
Sirona Biochem Enters into Research Agreement with University of British Columbia 18
Qu Biologics Enters into Research Agreement with University of British Columbia 19
InMed Pharma Enters into Agreement with University of British Columbia 20
Biommune Enters into Agreement with University of British Columbia 21
University of British Columbia Enters Into Agreement With Sichuan BoXin LaiTe Biotechnology And Heracles International Investment 22
Licensing Agreements 2
Commense Enters into Licensing Agreement with University of British Columbia 2
Roche Enters into Licensing Agreement with University of British Columbia and Vancouver Coastal Health Research Institute 24
BirchBioMed Enters into Licensing Agreement with University of British Columbia 25
Cyon Therapeutics Enters into Licensing Agreement with University of British Columbia 26
Cangene Enters Into Licensing Agreement With University of British Columbia 27
University of British Columbia - Key Competitors 28
University of British Columbia - Key Employees 29
University of British Columbia - Locations And Subsidiaries 0
Head Office 0
Other Locations & Subsidiaries 0
Recent Developments 2
Corporate Communications 2
Feb 19, 2018: UBC Board of Governors elects Michael Korenberg as new chair, Sandra Cawley, new vice-chair 2
Government and Public Interest
Feb 19, 2018: Government of Canada and Brain Canada announce a $10-million grant to establish a platform that will help researchers share data more widely and efficiently
Dec 20, 2017: A repurposed drug could open door to more stem cell transplants 5
Oct 0, 2017: Avon Foundation for Women (Canada) funds new breast cancer recovery trial in partnership with two Canadian universities 6
Sep 12, 2017: Alzheimer Society Research Program provides $.4 million boost to dementia research 7
Aug 0, 2017: Tracing single brain cancer cells simplifies complexity of incurable brain cancers, suggesting new treatments, international study finds 8
Jul 28, 2017: UBC researchers working to engineer tunable insulin production 40
Apr 24, 2017: MSFHR Funded Research Suggests Existence Of Pre-Clinical MS Symptoms 41
Feb 07, 2017: JDRF & Lilly Canada fund UBC research that could allow people with type 1 diabetes to produce their own insulin 42
Product News 4
Oct 26, 2017: Vanderbilt leads international effort to develop universal flu vaccine 4
Jan 18, 2018: Potential new diabetes treatment being tested in Vancouver 44
Clinical Trials 45
Feb 21, 2017: OncoGenex Pharmaceuticals Announces Phase 2 Apatorsen Data for Two Clinical Trials Presented at the American Society of Clinical Oncology (ASCO) 2017 Genitourinary Cancers Symposium 45
Other Significant Developments 46
Feb 09, 2018: $105-million investment to make prescription medications more affordable for families 46
Jan 2, 2018: Government of Canada announces support to help reduce HIV in British Columbia 47
Oct 26, 2017: The Human Vaccines Project Launches New Initiative To Accelerate Development Of Universally Effective Influenza Vaccines 49
Oct 17, 2017: Scientific Update for Diabetes, Kidney Ischemia, Liver Perfusion, Retinal Cell Replacement, Monoclonal Antibody Production and Immune Cell Cryopreservation Recovery 50
Oct 1, 2017: Putting new tools in the hands of leading Canadian scientists 52
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List Of Tables

List of Tables
University of British Columbia, Pharmaceuticals & Healthcare, Key Facts 2
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of British Columbia, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of British Columbia, Deals By Therapy Area, 2012 to YTD 2018 9
University of British Columbia, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ProtoKinetix Enters into Research Agreement with University of British Columbia 12
AXIM Biotech Enters into Agreement with University of British Columbia 13
Replicel Life Sciences Enters into Agreement with University of British Columbia 14
Ritter Pharma Enters into Agreement with University of British Columbia 15
TxCell Enters into Research Agreement with University of British Columbia 16
ProtoKinetix Enters into Research Agreement with University of British Columbia 17
Sirona Biochem Enters into Research Agreement with University of British Columbia 18
Qu Biologics Enters into Research Agreement with University of British Columbia 19
InMed Pharma Enters into Agreement with University of British Columbia 20
Biommune Enters into Agreement with University of British Columbia 21
University of British Columbia Enters Into Agreement With Sichuan BoXin LaiTe Biotechnology And Heracles International Investment 22
Commense Enters into Licensing Agreement with University of British Columbia 23
Roche Enters into Licensing Agreement with University of British Columbia and Vancouver Coastal Health Research Institute 24
BirchBioMed Enters into Licensing Agreement with University of British Columbia 25
Cyon Therapeutics Enters into Licensing Agreement with University of British Columbia 26
Cangene Enters Into Licensing Agreement With University of British Columbia 27
University of British Columbia, Key Competitors 28
University of British Columbia, Key Employees 29
University of British Columbia, Other Locations 30
University of British Columbia, Subsidiaries 30

List Of Figures

List of Figures
University of British Columbia, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of British Columbia, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

OH – San Juan de Dios University Hospital Development – Sevilla - Project Profile

Synopsis OH San Juan de Dios University Hospital Development Sevilla - Project Profile contains information on the scope of the project including project overview and location. The profile also

USD 75View Report

BLBNRW – Aachen University Hospital Complex – North Rhine-Westphalia - Project Profile

Synopsis BLBNRW Aachen University Hospital Complex North Rhine-Westphalia - Project Profile contains information on the scope of the project including project overview and location. The profile also details project

USD 75View Report

Catholic University of Leuven - Medical Equipment - Deals and Alliances Profile

Catholic University of Leuven (KU Leuven) is a scientific research and educational service provider that offers bachelors degree, post graduate degree and doctorate degree programs. The university offers educational courses

USD 250View Report

University of Cambridge - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

University of Cambridge - Mergers & Acquisitions (M&A), Partnerships & Alliances and InvestmentsMarketlines University of Cambridge Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed

USD 350View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Mar 2018
No. of Pages :54
Country :Canada
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube